Division of Strategic Planning and Evaluation FY2019 List of Projects - Research Program on Emerging and Re-emerging Infectious Diseases

First Year Final Year Principal Investigator Affiliation Project Title
FY2017 FY2019 Jiro Yasuda Nagasaki University Professor Research and development of therapeutics, diagnostics and preventive measures for containment of viral hemorrhagic fevers
FY2017 FY2019 Yoshihiro Kawaoka The University of Tokyo Professor Development of next generation Ebola virus vaccines
FY2017 FY2019 Tsutomu Kageyama National Institute of Infectious Diseases Chief Development of diagnostic function for emerging pandemic influenza viruses and respiratory viruses
FY2017 FY2019 Shinji Watanabe National Institute of Infectious Diseases Chief Prediction models of novel antigenic variants of seasonal influenza viruses and application for selection of viruses for influenza vaccine
FY2017 FY2019 Makoto Takeda National Institute of Infectious Diseases Director Research for development of laboratory systems for national and global surveillance for respiratory syncytial virus
infection
FY2017 FY2019 Hirokazu Kimura Gunma Paz University Professor Studies on molecular epidemiology and epidemic prediction of the gastroenteric virus infections
FY2017 FY2019 Yuichi Someya National Institute of Infectious Diseases Senior Researcher Studies on pathogenesis of diarrheal viruses and development of anti-viral drugs and vaccines
FY2017 FY2019 Chang-Kweng Lim National Institute of Infectious Diseases Chief Establishing surveillance system for the risk of outbreaks of emerging and re-emerging insect-borne diseases in Japan and  developing comprehensive insect-borne virus control system
FY2017 FY2019 Yoshiharu Matsuura Osaka University Director, Professor Characterization of host factors involved in the propagation and pathogenesis of insect-borne viruses and development of preventive and therapeutic measures targeting these host factors
FY2017 FY2019 Isao Hamaguchi National Institute of Infectious Diseases Director Epidemiological study regarding HTLV-1 infection and comprehensive effective strategy for its infection inhibition
FY2017 FY2019 Tetsuro Matano National Institute of Infectious Diseases Director Development of a vaccine against HTLV-1 prevalence and disease progression
FY2017 FY2019 Kaoru Uchimaru The University of Tokyo Professor Investigation of Putative Common Mechanism of ATL/HAM Development and Clinical Entity of Chronic Active HTLV-1 Infection
FY2017 FY2019 Akifumi Takaori-Kondo Kyoto University Professor Study on the impaired DNA repair induced by HTLV-1 infection and its role in leukemogenesis and development of a novel therapeutic strategy
FY2017 FY2019 Seiya Kato The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association Director Multi-dimensional research on strengthening tuberculosis control program in Japan to accelerate tuberculosis low incidence
FY2017 FY2019 Toshio Hattori KIBI International University Professor Comprehensive Strategies against Multidrug-Resistant Tuberculosis utilizing Overseas Networks
FY2017 FY2019 Manabu Ato National Institute of Infectious Diseases Director Establishment of epidemiological investigation, diagnostic tools, and therapeutics of non-tuberculous mycobacteria
FY2017 FY2019 Tadayoshi Ikebe National Institute of Infectious Diseases Senior researcher Research on the pathogenesis-related factors of streptococcal toxic shock syndrome and research towards development of novel therapeutic methods
FY2017 FY2019 Yoshitsugu Miyazaki National Institute of Infectious Diseases Director Investigation of breakthrouh innovation for prevalence, novel diagnosis and treatment to overcomethe invasive fungal infection by yeasts
FY2017 FY2019 Tomoyoshi Nozaki The University of Tokyo Professor Integrated Project on Development of New Diagnostics, Surveillance System, Pathogen Genome Database, and Elucidation of Mechanisms of Drug Resistance, Pathogenesis and Parasitism
FY2017 FY2019 Masahiro Yamamoto Osaka University Professor Research and Development for Comprehensive Measures against Toxoplasmosis
FY2017 FY2019 Makoto Kuroda National Institute of Infectious Diseases Director Genomics application for controlling antimicrobial resistant-bacteria using an integrated database of pathogen genomics and epidemiology (GenEpid-J)
FY2017 FY2019 Makoto Ohnishi National Institute of Infectious Diseases Deputy Director-General Construction of laboratory network among the research institutions for infectious diseases in Asian countries
FY2017 FY2019 Hiroshi Nishiura Hokkaido University Professor Project organization and implementation of epidemiological modeling studies of infectious diseases for assisting healthcare assosciated policy making
FY2017 FY2019 Yoshimasa Takahashi National Institute of Infectious Diseases Director Rational design of novel vaccines with improved efficacy and safety
FY2017 FY2019 Katsunori Yanagihara Nagasaki University Professor Research and development of diagnostic methods and therapies for antimicrobial resistant bacteria
FY2017 FY2019 Tetsuro Suzuki Hamamatsu University School of Medicine Professor Understanding of dynamics of Zika virus infection and its immune responses in the common marmoset model
FY2017 FY2019 Yoshitoshi Ogura Kyushu University Associate professor Development of new therapeutic strategy for enterohemorrhagic Escherichia coli infection using Shiga toxin-neutralizing plastic antibody
FY2017 FY2019 Takeshi Noda Kyoto University Professor Antiviral drug development for Ebola virus disease and Lassa fever
FY2018 FY2020 Yoshihiro Kawaoka The University of Tokyo Professor Study on risk assessment and vaccine development for highly pathogenic avian H7N9 influenza viruses emerged in China
FY2018 FY2020 Eri Nobusawa National Institute of Infectious Diseases Lab chief Study of the cell-based influenza vaccine
FY2018 FY2020 Tsuneo Morishima Aichi Medical University Visitng Professor Research on the diagnosis and treatment of severe respiratory infections caused by viruses
FY2018 FY2020 Takuo Mizukami National Institute of Infectious Diseases Section Chief Development of hyper-immune-Globulin against HTLV-1 infection and disease progression
FY2018 FY2020 Yuetsu Tanaka University of the Ryukyus Professor Generation of recombinant human immunoglobulin drugs and verification using a non-human primatemodel for development of passive immunization prophylaxis against mother to child vertical infection with HTLV-1
FY2018 FY2020 Keigo Shibayama National Institute of Infectious Diseases Director Research and development of new technologies for comprehensive infection control of emerging and re-emerging Antimicrobial Resistance
FY2018 FY2020 Makoto Ohnishi National Institute of Infectious Diseases Deputy Director-General Research for control of antimicrobial resistant Neisseria gonorrhoeae infection
FY2018 FY2020 Satoshi Mitarai The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association Professor/Head Technology development for tuberculosis infection control with OMICS information
FY2018 FY2020 Yoshihiko Hoshino National Institute of Infectious Diseases Division Chair Studies toward the development of prophylaxis, diagnosis and treatment of leprosy and other mycobacterial skin diseases
FY2018 FY2020 Sunao iyoda National Institute of Infectious Diseases Chief Research for the establishment of surveillance method and virulence evaluation system of deiarrheagenic enterobacteria
FY2018 FY2020 Motoi Suzuki National Institute of Infectious Diseases Director Researches on surveillance for vaccine-preventable diseases and evaluation of vaccine effectiveness
FY2018 FY2020 Kyoko Sawabe National Institute of Infectious Diseases Senior Researcher Studies of arthropods involved in vector-borne diseases
FY2018 FY2020 Shuji Ando National Institute of Infectious Diseases Chief Research for syntetic strategy of tick-borne bacterial diseases
FY2018 FY2020 Ken Maeda National Institute of Infectious Diseases Director Establishment of system for diagnosis and information sharing of zoonosis transmitted by companion animals
FY2018 FY2020 Shuetsu Fukushi National Institute of Infectious Diseases Director Research on the improvement of the bio-risk management systems of highly pathogenic agents
FY2018 FY2020 Ryoichi Saito Tokyo Medical and Dental University Associate professor Research and development of effective testing and surveillance strategies for meningococcal disease in mass gatherings
FY2018 FY2020 Masayuki Saijo National Institute of Infectious Diseases Director Research on the therapeutic and preventive measures against highly pathogenic virus infections: development of vaccines to and animal models of highly pathogenic virus infections
FY2018 FY2020 Ichiro Nakagawa Kyoto University Professor Construction of optimized antibody production platform for development of new diagnostic and therapeutic drugs against bacterial infections
FY2018 FY2020 Yasuo Yoshioka Osaka University Specially-Appointed Associate Professor Creation of dendritic cell-targeting peptides as vaccine delivery vehicle for the development of vaccine against infectious diseases
FY2018 FY2020 Yoshihiko Hoshino National Institute of Infectious Diseases Division Chair The development of novel treatment strategy regarding the functional comprehension of inducible and inhibitory innate receptor under the latency and re-activation of mycobacterial infection
FY2018 FY2020 Atsushi Kawaguchi University of Tsukuba Associate Professor Molecular basis for mammalian adaptation of emerging influenza virus
FY2018 FY2020 Ryohei Hirose Kyoto Prefectural University of Medicine Assistant Professor Analysis of the onset mechanism and clinicopathological characteristics of seasonal influenza-related enteritis
FY2018 FY2020 Yoshiki Fujii National Institute of Infectious Diseases Senior Researcher Molecular epidemiological study of rotaviruses based on full genome analysis after vaccine introduction
FY2018 FY2020 Shogo Ozaki Kyushu University Associate Professor A novel approach to identify selective inhibitors for microbial biofilms
FY2019 FY2021 Masayuki Shimojima National Institute of Infectious Diseases Chief Research on diagnosis, treatment, and preventive measures of emerging and re-emerging infectious diseases including viral hemorrhagic fevers
FY2019 FY2021 Masayuki Saijo National Institute of Infectious Diseases Director Development of preventive measures of severe fever with thrombocytopenia syndrome (SFTS)
FY2019 FY2021 Noriko Nakajima National Institute of Infectious Diseases Chief International collaborative research on diagnosis and treatment based on clinicopathological study of severe respiratory infections including novel influenza
FY2019 FY2021 Hideki Hasegawa National Institute of Infectious Diseases Director Establishment of fundamental technologies for clinical use of an intranasal influenza vaccine
FY2019 FY2021 Hiroyuki Shimizu National Institute of Infectious Diseases Chief Study of the development of diagnostic, therapeutic, and preventive strategies for emerging and re-emerging enterovirus infections
FY2019 FY2021 Minetaro Arita National Institute of Infectious Diseases Senior research scientist Development of poliovirus neutralization test with poliovirus pseudovirus
FY2019 FY2021 Yoshio Mori National Institute of Infectious Diseases Chief Study to strengthen the surveillance for measles and rubella
FY2019 FY2021 Minoru Kidokoro National Institute of Infectious Diseases Chief Study on the development of safe and effective novel mumps vaccines based on both long-term and short-term viewpoint
FY2019 FY2021 Masao Matsuoka Kumamoto University Professor Predictive strategy of HTLV-1-associated diseases based on host/viral genomic data and development of an integrated database of clinical and genomic Information
FY2019 FY2021 Toshiki Tamura National Institute of Infectious Diseases Laboratory Head Development of new tools to detect latent TB and high-risk individuals, effective recombinant BCG vaccine and booster vaccine, and new drugs for treatment of multidrug resistant tuberculosis, for global tuberculosis control
FY2019 FY2021 Naoto Keicho The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association Vice Director Study on biological factors for prediction of disease risk and shorter treatment of tuberculosis
FY2019 FY2021 Masuyoshi Saito Tokyo Medical University Assistant Professor Research and development contributing to rapid diagnosis of syphilis
FY2019 FY2021 Takeshi Murata Chiba University Professor Development of new antibacterial drug targeting V-ATPase in Vancomycin-resistant Enterococcus (VRE)
FY2019 FY2021 Masato Suzuki National Institute of Infectious Diseases Senoir Reseacher Development of novel antibacterial agents by reevaluating old antibiotics and repositioning approved drugs
FY2019 FY2021 Shigeru Kohno Nagasaki University President Developmental study of innovative diagnostics and therapeutics against invasive fungal infections, including management of antifungal resistance
FY2019 FY2021 Haruhiko Maruyama University of Miyazaki Professor Development of optimal medical care network for the diagnosis, treatment, and prevention for tropical and parasitic diseases in Japan
FY2019 FY2021 Hajime Hisaeda National Institute of Infectious Diseases Director Analyses of CNS pathogenesis by parasites and its application to diagnostic and therapeutic strategies
FY2019 FY2021 Shigeru Morikawa Okayama University of Science Professor Studies on examination, diagnosis and prevention methods that contribute to control of zoonoses
FY2019 FY2021 Koji Matsumoto Showa University School of Medicine Professor Study for monitoring the impact of a national HPV vaccination program in Japan (MINT study II)
FY2019 FY2021 Shigeru Suga National Hospital Organization Mie National Hospital Vice Director Research on vaccine effectiveness and safety in widely vaccinated population and evaluation and development of vaccine
FY2019 FY2021 Koji Ishii National Institute of Infectious Diseases Director Study of the development and improvement of quality control of vaccines for various infectious diseases
FY2019 FY2021 Manabu Ato National Institute of Infectious Diseases Director Study of antitoxin/antivenom therapy and replacement for humanized monoclonal antibodies
FY2019 FY2021 Masamichi Muramatsu National Institute of Infectious Diseases Director Establishment of infection systems for viruses that are difficult to replicate in vitro and in vivo, and its application to the development of novel diagnosis, treatment and prevention methods
FY2019 FY2021 Makoto Kuroda National Institute of Infectious Diseases Director Study of development of genome-based comprehensive and rapid pathogen detection system
FY2019 FY2021 Tadaki Suzuki National Institute of Infectious Diseases Chief Development of pathological diagnostic methods for congenital infections and unexplained illness of possible infectious etiology
FY2019 FY2021 Yasushi Kawaguchi The University of Tokyo Professor Establishment of novel methods for decoding viral protein coding genes
FY2019 FY2021 Tomomi Nakahara National Cancer Center Staff scientist Development of genome editing based therapy of papillomavirus infected lesions with all in one adenovirus vectors expres sing super multicopy guide RNA and Cas9 nickase
FY2019 FY2021 Shinji Saito National Institute of Infectious Diseases Postdoctoral fellow Escape mechanism of influenza virus from anti-HA stem antibody and the application of escape mutant viruses
FY2019 FY2021 Yuki Furuse Kyoto University Project Assistant Professor Epidemiological and virological study of severe RS virus infection
FY2019 FY2021 Moi Meng Ling Nagasaki University Associate Professor Study of neutralizing antibody repertoire in modulating dengue protection for vaccination strategies

Last updated 07/17/19